Pamishield

Activity by year

2017201820192020202120222023202420252026

Contract

Jan 10, 2020CONTRACTSouth Korea$1.13M
Pamishield signs KRW 1.3B supply deal with UCB Pharma
Pamishield has signed a contract with UCB PHARMA S.A. to supply the pharmaceutical intermediate mPEG. The contract is valued at KRW 1,325,300,000 and runs until June 29, 2020.
Pamishield supplier UCB PHARMA S.A. customer #Specialty Chemicals biz.heraldcorp.com
Jan 23, 2017CONTRACTSouth Korea
Pamishield signs 6-year supply contract with UCB for mPEG-20k
Pamishield (파미셀) signed a 6-year contract with Belgian pharmaceutical company UCB to supply mPEG-20k, a raw material for the autoimmune disease drug Cimzia. The contract is effective from January 23, 2017, with automatic one-year renewals thereafter.
Pamishield supplier UCB customer #Specialty Chemicals medicaltimes.com

Customers

Loading…

Pamishield: plants, expansions, contracts and acquisitions · Endata